secwatch / observer
8-K filed March 1, 2023, 6:59 PM ET ticker MRMD CIK 0001522767
earnings confidence high sentiment neutral materiality 0.70

MariMed Q4 revenue up 15.5% YoY to $35.8M; net income turns positive but EBITDA margin shrinks

MARIMED INC.

2022-FY EPS reported $0.04 revenue$134,010,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

MARIMED INC. reported year ended December 31, 2022 results: revenue $134.0, net income $13.6.

Period
year ended December 31, 2022
Revenue
$134.0
Net income
$13.6
Result
reported results
Exact text from the filing
2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2 $ 0.1 $ 22.2 $
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 1.0

MARIMED INC. reported three months ended December 31, 2022 results: revenue $35.8, net income $4.8.

Period
three months ended December 31, 2022
Revenue
$35.8
Net income
$4.8
Result
reported results
Exact text from the filing
December 31, 2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2
View on SEC.gov

Browse all earnings releases →

MARIMED INC. filing history →

Source: SEC EDGAR
accession 0001522767-23-000009
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.